Newsroom

Sorted by: Latest

-

INVESTOR ALERT: Securities Class Action Filed Against Verra Mobility Corporation – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) securities during the period of February 24, 2026 through May 26, 2026, inclusive (“the Class Period”).If you suffered a loss on your Verra Mobility investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff ap...
-

PointsBet Goes All In on Grafana Cloud to Power AI-Driven Observability at Scale

SYDNEY--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced that PointsBet, one of Australia’s fastest-growing digital wagering operators, has selected Grafana Cloud as its unified observability platform. PointsBet is using Grafana Cloud to consolidate telemetry across its proprietary betting platform, accelerate incident resolution with AI-powered insights, and give engineering teams the visibility they need to own and operate their services with con...
-

Diabetology veröffentlicht bahnbrechende klinische Daten zu dem oralen GLP-1-Präparat Oraglutide™

NEW ORLEANS--(BUSINESS WIRE)--Posterpräsentation von Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P im Rahmen der 86. ADA-Wissenschaftstagung in New Orleans, in der erste Daten aus Humanstudien zu Oraglutide™ vorgestellt wurden — einem in kleinen Kapseln verabreichten, im Darm freigesetzten oralen Semaglutid, das unter Verwendung der firmeneigenen Axcess™-Verabreichungstechnologie entwickelt wurde. DIE WICHTIGSTEN HIGHLIGHTS 6-Tage-Glukosekontrolle: Eine einmalige or...
-

INVESTOR ALERT: Securities Class Action Filed Against PicS N.V. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired PicS N.V. (“PicS” or the “Company”) (NASDAQ:PICS) securities during the period from January 27, 2026 through June 5, 2026. If you suffered a loss on your PicS investments, you have until August 4, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted after this deadline. If you choose to take no...
-

Resumen: ¡Resident Evil Veronica se lanzará en 2027!

OSAKA, Japón--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) anunció hoy que Resident Evil Veronica, el juego más reciente de la serie Resident Evil, tiene fecha de lanzamiento prevista para 2027. La franquicia Resident Evil incluye juegos de terror de supervivencia donde los jugadores utilizan una serie de armas y otros objetos para sobrevivir en situaciones aterradoras. Con el apoyo de una base de fanáticos global apasionada, las ventas de juegos totales desde el primer lanzamiento de esta se...
-

Données cliniques révolutionnaires de Diabetology sur l’Oraglutide™, un GLP-1 oral

NOUVELLE-ORLÉANS--(BUSINESS WIRE)--Présentation par affiche de Diabetology Limited (Jersey) (https://diabetology.co.uk/ada-poster) 1724-P lors de la 86e session scientifique de l’ADA, à La Nouvelle-Orléans, rendant compte des premières données humaines sur l’Oraglutide™, une petite capsule de séma-glutide oral à libération intestinale, formulée à l’aide de la technologie de délivrance exclusive Axcess™. POINTS CLÉS Contrôle glycémique sur 6 jours : une dose orale unique de 4 mg d’Oraglutide™ a...
-

ClickHouse Appoints New Leader for Asia Pacific and Expands Global Go-To-Market Leadership Team

SAN FRANCISCO--(BUSINESS WIRE)--ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced a significant expansion of its global go-to-market (GTM) leadership team, headlined by the appointment of Ed Lenta as Vice President, Asia Pacific and Japan (APJ). The additions build on the momentum established last year with the appointment of Kevin Egan as Chief Revenue Officer, and reflect ClickHouse's strategic investment in scaling its global organizatio...
-

Diabetology發表Oraglutide™口服GLP-1激動劑的突破性臨床資料

紐奧良--(BUSINESS WIRE)--(美國商業資訊)-- Diabetology Limited (Jersey) 在紐奧良舉行的第86屆美國糖尿病協會(ADA)科學年會上,以海報演說會形式(https://diabetology.co.uk/ada-poster ) 1724-P展示了Oraglutide™的首批人體資料。Oraglutide™是一種小膠囊腸道釋放型口服索馬魯肽,採用專有的Axcess™遞送技術配製而成。 主要亮點 6天血糖控制:單次口服4毫克Oraglutide™即可達到血糖持續下降。在第6天測得14%的療效(p=0.046),這是在人體靜脈葡萄糖耐受試驗(IVGTT)研究中,單次口服GLP-1給藥後持續時間最長的療效。 胰島素分泌增加28%:與安慰劑相比,胰島素AUC百分比在第0天增加12%(p=0.02),第1天增加28%(p=0.025)。 新型腸道緩釋作用:第1天的索馬魯肽血中濃度高於第0天,與腸壁脂質相關的緩釋作用一致,是一項全新的藥理學發現。 未觀察到噁心或副作用:在為期一周的8名受試者群組中,未觀察到任何不良反應,這與針對迷走神經傳入機制進行治...
-

Samenvatting: Resident Evil Veronica wordt in 2027 gelanceerd!

OSAKA, Japan--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) kondigde vandaag aan dat Resident Evil Veronica, de nieuwste titel in de Resident Evil-serie, volgens planning in 2027 zal uitkomen. De Resident Evil-franchise omvat overlevingshorrorgames waarin spelers een verscheidenheid van wapens en andere middelen gebruiken om huiveringwekkende situaties te overleven. Gesteund door een wereldwijde gepassioneerde fanbase, overschrijdt de cumulatieve verkoop van de game sinds de eerste titel in de...
-

Diabetology发布Oraglutide™口服GLP-1的突破性临床数据

新奥尔良--(BUSINESS WIRE)--(美国商业资讯)-- Diabetology Limited (Jersey)在美国糖尿病协会(ADA)第86届科学会议(新奥尔良)上进行海报展示(https://diabetology.co.uk/ada-poster,编号1724-P),报告了Oraglutide™的首批人体数据——这是一种采用专有Axcess™递送技术制备的、可在肠道释放的小胶囊口服司美格鲁肽制剂。 主要亮点 6天血糖控制:单次口服4毫克Oraglutide™可使血糖水平持续下降。第6天时降幅达14%(p=0.046),这是迄今为止在人类静脉葡萄糖耐量试验(IVGTT)中,单次口服GLP-1制剂所呈现的最长持续时间。 胰岛素分泌增加28%:与安慰剂相比,胰岛素的百分比AUC在第0天增加了12%(p=0.02),在第1天增加了28%(p=0.025)。 新型肠道储库效应:第1天的司美格鲁肽血药浓度高于第0天的给药浓度,这与肠壁中脂质相关的储库效应一致,是一项具有根本性突破的药理学发现。 未观察到恶心或副作用:在一周内,该8名受试者队列中未观察到任何不良事件,这与针对迷走...